Continuous engagement of a self-specific activation receptor induces NK cell tolerance

Por Tripathy, Sandeep K., Keyel, Peter A., Yang, Liping, Pingel, Jeanette T., Cheng, Tammy P., Schneeberger, Achim, Yokoyama, Wayne M.
Publicado em 2008

Tailoring the Antibody Response to Aggregated Aß Using Novel Alzheimer-Vaccines

Por Mandler, Markus, Santic, Radmila, Gruber, Petra, Cinar, Yeliz, Pichler, Dagmar, Funke, Susanne Aileen, Willbold, Dieter, Schneeberger, Achim, Schmidt, Walter, Mattner, Frank
Publicado no PLoS One (2015)

Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management

Por Galabova, Gergana, Brunner, Sylvia, Winsauer, Gabriele, Juno, Claudia, Wanko, Bettina, Mairhofer, Andreas, Lührs, Petra, Schneeberger, Achim, von Bonin, Arne, Mattner, Frank, Schmidt, Walter, Staffler, Guenther
Publicado no PLoS One (2014)

Next-generation active immunization approach for synucleinopathies - implications for Parkinson’s Disease clinical trials

Por Mandler, Markus, Valera, Elvira, Rockenstein, Edward, Weninger, Harald, Patrick, Christina, Adame, Anthony, Santic, Radmila, Meindl, Stefanie, Vigl, Benjamin, Smrzka, Oskar, Schneeberger, Achim, Mattner, Frank, Masliah, Eliezer
Publicado em 2014

Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy

Por Mandler, Markus, Valera, Elvira, Rockenstein, Edward, Mante, Michael, Weninger, Harald, Patrick, Christina, Adame, Anthony, Schmidhuber, Sabine, Santic, Radmila, Schneeberger, Achim, Schmidt, Walter, Mattner, Frank, Masliah, Eliezer
Publicado no Mol Neurodegener (2015)